Counterfeit drugs pose a significant threat to public health, as they may contain incorrect ingredients, improper dosages, or harmful substances. Traditional pharmaceutical supply chains lack transparency, making it difficult to track and verify the authenticity of drugs, increasing the risk of counterfeit medications reaching consumers.

This startup provides a blockchain-based platform for tracking and tracing pharmaceutical products throughout the supply chain, from manufacturing to distribution and dispensing. By recording each transaction and movement of a drug on an immutable, distributed ledger, the platform creates a transparent and auditable record of its provenance. This allows stakeholders, including manufacturers, distributors, pharmacies, and regulators, to verify the authenticity of drugs and identify potential points of diversion or counterfeiting. The platform enhances supply chain security, reduces the risk of counterfeit drugs entering the market, and improves patient safety.

Blockchain-based tracking and tracing of pharmaceutical products

Immutable and transparent record of drug provenance

Real-time visibility into the supply chain

Secure data sharing among stakeholders

Verification of drug authenticity

Identification of potential points of diversion or counterfeiting

Compliance with regulatory requirements

The primary customers are pharmaceutical manufacturers, distributors, pharmacies, and regulatory agencies seeking to enhance supply chain security and combat drug counterfeiting.